1. Home
  2. PDSB vs BRID Comparison

PDSB vs BRID Comparison

Compare PDSB & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • BRID
  • Stock Information
  • Founded
  • PDSB 2005
  • BRID 1932
  • Country
  • PDSB United States
  • BRID United States
  • Employees
  • PDSB N/A
  • BRID N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • BRID Specialty Foods
  • Sector
  • PDSB Health Care
  • BRID Consumer Staples
  • Exchange
  • PDSB Nasdaq
  • BRID Nasdaq
  • Market Cap
  • PDSB 72.2M
  • BRID 70.3M
  • IPO Year
  • PDSB N/A
  • BRID N/A
  • Fundamental
  • Price
  • PDSB $1.62
  • BRID $7.65
  • Analyst Decision
  • PDSB Strong Buy
  • BRID
  • Analyst Count
  • PDSB 2
  • BRID 0
  • Target Price
  • PDSB $10.00
  • BRID N/A
  • AVG Volume (30 Days)
  • PDSB 855.2K
  • BRID 1.9K
  • Earning Date
  • PDSB 08-12-2025
  • BRID 06-02-2025
  • Dividend Yield
  • PDSB N/A
  • BRID N/A
  • EPS Growth
  • PDSB N/A
  • BRID N/A
  • EPS
  • PDSB N/A
  • BRID N/A
  • Revenue
  • PDSB N/A
  • BRID $224,673,000.00
  • Revenue This Year
  • PDSB N/A
  • BRID N/A
  • Revenue Next Year
  • PDSB N/A
  • BRID N/A
  • P/E Ratio
  • PDSB N/A
  • BRID N/A
  • Revenue Growth
  • PDSB N/A
  • BRID N/A
  • 52 Week Low
  • PDSB $0.85
  • BRID $7.52
  • 52 Week High
  • PDSB $4.42
  • BRID $14.69
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 54.15
  • BRID 40.57
  • Support Level
  • PDSB $1.53
  • BRID $7.64
  • Resistance Level
  • PDSB $1.85
  • BRID $7.88
  • Average True Range (ATR)
  • PDSB 0.14
  • BRID 0.17
  • MACD
  • PDSB -0.01
  • BRID -0.01
  • Stochastic Oscillator
  • PDSB 44.86
  • BRID 6.38

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

Share on Social Networks: